Fwd: TWO OPTIONS AS ON 21.08.09

looking at yeterday's upmove and global markets it seems we have completed downmove which started from 16002 at 14684 . as  i had discussed earlier that we may be in 5th wave than this upmove will be third sub wave to be followed by 4th dn and 5th up.

 

as i had shown in alternative wave count that if we are  correcting as Ba-Bb-Bc than we will be on last upmoving sub wave Bc-c. i have shown both options in attached chart.

 

sensex levels :- as discussed yesterday in 5 day charts first target and hurdle will be around 15500 and on crossing it , next hurdle comes at 16000 prev top.on crossing 16k we may face strong resistance betn 16200-16500 area and valuations will be also on higher side.so i think it will be advisable move to book profits on crossing 16k in investments .

 

i have shown rsi trend lines also in chart which are helping us in short term moves on both sides which can be tarcked by u on sensex charts easily. as it is always seen in last leg of rally now outperformance and heavy volumes r seen in mid and small cap stocks.care is to be taken that we r not stuck with high valued stocks at end of rally. so necessary strict stop losses r needed.

 

STOP LOSSES FOR LONG POSITIONS . FIRST AT 15135 AND SECOND 14684.

i will like to remind another bullish option i have been discussuing was 5th wave of first upmove and i had given wave count as below

13220-14493
14493-14170
14170-16002
16002-14684
14684-running

more over as per vivek patil analysis of 7 legged upmove a-b-c-d-e-f-g we might have completed f and we may be on g now to end this bull run.



SMALL CORRECTION: IN CHART WAVES R SHOWN AS d AND e. THEY SHD BE READ AS 4 AND 5 TO MATCH WITH NARRATION.

5 DAY CHAT

LOOK AT CHART 1, 2 AND 3

 

http://pankaj564.blogspot.com/2009/08/fwd-5-day-chart.html

 

 

 

http://pankaj564.blogspot.com/2009/08/fwd-5-day-chart_21.html

buy ghcl at 42

call from technical analyst NOORESH MERANI

 

buy GHCL at 42

 

target 47

 

stop loss 39.5

Fwd: 5 day chart

look at chart

Fwd: 5 DAY CHART

LOOK AT 5 DAY CHART

OBSERVE FERTILISER STOCKS

FERTILISER STOCKS R COORECTING SINCE LONG AND YESTERDAY TEHY HAVE SHOWN SOME VOLUMES. IF VOLUME EXPANSION ALONGWITH PRICE APPRICIATION IS SEEN BUYING CAN BE DONE IN STOCKS LIKE DEEPAK FERTILISER, CHAMABAL FERTILISER.

Fwd: alternative wave count

have a look at chart. i have tried to put an alternative wave count to justify last upmove.

Panacea Biotec hits the roof on large order

Panacea Biotec hits the roof on large order

Panacea Biotec was locked at 5% upper limit at Rs 174 at 13:11 IST on BSE, having recovered from the session's low of Rs 160.10, after the company bagged an order worth $222.37 million for supply of a vaccine.


At the day's low of Rs 160.10, the stock slumped 3.41% before the company made this announcement during trading hours.

Meanwhile, the BSE Sensex was down 318.95 points, or 2.12%, to 14,716.31.

On BSE, 33,229 shares were traded in the counter. The stock had an average daily volume of 19,439 shares in the past one quarter.

The stock hit a high of Rs 174 and a low of Rs 160.10 so far during the day. The stock hit a 52-high of Rs 316 on 25 August 2008 and a 52-week low of Rs 51 on 2 February 2009.

The mid-cap stock had outperformed the market over the past one month till 17 August 2009, gaining 25.75% as compared to the Sensex's 0.27% rise. It had also outperformed the market in the past one quarter, surging 77.93% as compared to the Sensex's return of 21.45%.

The company's current equity is Rs 6.68 crore. Face value per share is Rs 1.

The current price of Rs 174 discounts the company's Q1 June 2009 annualized EPS of Rs 7.80, by a PE multiple of 22.31.

The company has secured a contract worth $222.37 million (Rs 1067 crore) from United Nations Children's Fund (UNICEF) for supplying EasyFive (pentavalent vaccine) for three years (from 2010 to 2012).

EasyFive is world's first fully liquid pentavalent vaccine introduced in India by Panacea Biotec in January 2009. The drug immunizes children against five dreadful diseases in early childhood.

The company had received the pre-qualification for EasyFive from the World Health Organization (WHO) in July last year.

Panacea Biotec's net profit fell 61.7% to Rs 13.03 crore on 21.1% fall in net sales to Rs 177.21 crore in Q1 June 2009 over Q1 June 2008.

Panacea Biotec operates a pharmaceutical company in India, which manufactures a variety of drugs that are distributed internationally. The company's key products include a Hepatitis B vaccine and drugs for diabetes management.


source : capital market

Fwd: STOCK TO WATCH GDL CMP RS. 93.00

BUY GDL CMP 93

TARGET 100

STOP LOSS 90

Fwd: SENSEX AS ON 19.08.09

COMMENTS ON CHART.

14283 CAN BE KEPT AS STOP LOSS FOR LONG POSITIONS.